Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    

| More

Karur Vysya Bank - Earnings improve, but concerns persist - ICICI Securities

Posted On: 2020-08-01 22:09:06

Karur Vysya Bank's (KVB) Q1FY21 earnings revived to Rs1bn, taking RoA to a multi-quarter high of 0.6% led by cost flexibility and lower provisioning. Other operating expenses fell 7% QoQ despite a one-time impact of Rs227mn towards wage hike settlement at 15%; adjusted for the one-off, opex would have been down by ~13%. However, KVB's lack of intent to build contingency buffer (currently at ~25bps of loans) was a surprise especially after considering its relatively higher Morat 2.0 book at ~41% (not considering partial repayments) and cushion of strong treasury gain of Rs1.8bn. Asset quality improved though driven by lower slippages at Rs0.4bn (as expected) due to moratorium and higher write-offs at >Rs1bn. The improvement was consistent through past five quarters with GNPL ratio falling to 8.3% in Q1FY21 from 9.2% in Q1FY20. While we believe KVB's upgraded digital platform, cost optimisation drive, sharp improvement in coverage ratio over the past couple of years, is likely to revive RoA to 0.6% by FY22E, management change and lower contingency buffer poses risk to near-term asset quality and growth. Maintain HOLD.

- Loan mix continued to tilt towards retail; incremental lending in corporate portfolio (above Rs1bn ticket size) is strictly towards 'AA & above rated' or government entities. Overall credit growth remained subdued with total loans contracting by 1% YoY and flat QoQ mainly due to: 1) management's conservative strategy to consolidate the corporate portfolio, down 12%/6% YoY/QoQ; however, the increased proportion of >Rs1bn in corporate portfolio is surprising; 2) IBPC repayment in retail segment, down 2% QoQ; but strong growth in gold loan book at 26%/8% YoY/QoQ, largely classified under agri portfolio, restricted further decline in advances. Management sounded cautious about growing the balance sheet in current environment and would reassess the situation post-moratorium in Aug'20.

- Liability strength visible in strong CASA accretion. Total deposits grew 2% QoQ, largely driven by strong CASA accretion with CA balance growing by 12% QoQ and SA balance growing by 6% QoQ, taking CASA ratio to an all-time high of 33%. The benefits of lower cost of fund is likely to flow in P&L in the coming quarters and the same is likely to arrest the currently downtrending margin trajectory.

- Digital journey remained on track: Over past couple of years, KVB has completely transformed its digital platform with most of its asset products already migrated to it. KVB initiated a second phase of transformation by realigning key business processes with the revamped platform. The same is likely to release ~540 staff (~100 net decline in Q1FY21) and save Rs240mn (~4bps of total assets) in manpower costs.

- Asset quality improved, but driven by write-offs. While fresh slippages came in lower at Rs0.4bn (0.4% slippage ratio), due to ongoing moratorium, asset quality improvement was mainly driven by higher write-offs at >Rs1bn. Management expects credit cost to remain between 1.55-2.5% in FY21E.

Shares of KARUR VYSYA BANK LTD. was last trading in BSE at Rs.34.4 as compared to the previous close of Rs. 34.4. The total number of shares traded during the day was 821025 in over 2729 trades.

The stock hit an intraday high of Rs. 35.9 and intraday low of 33.65. The net turnover during the day was Rs. 28863528.

Source: Equity Bulls

Click here to send ur comments or to

Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only., its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.

Other Headlines:

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities


Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019